Pain Medicine最新文献

筛选
英文 中文
Evaluation of a novel nerve ablation technique to relieve lower back pain: A cadaveric feasibility pilot study. 评估缓解下背痛的新型神经消融技术:尸体可行性试验研究。
IF 2.9 3区 医学
Pain Medicine Pub Date : 2024-11-06 DOI: 10.1093/pm/pnae112
Charlotte Jones-Whitehead, John Tran, Timothy D Wilson, Eldon Loh
{"title":"Evaluation of a novel nerve ablation technique to relieve lower back pain: A cadaveric feasibility pilot study.","authors":"Charlotte Jones-Whitehead, John Tran, Timothy D Wilson, Eldon Loh","doi":"10.1093/pm/pnae112","DOIUrl":"https://doi.org/10.1093/pm/pnae112","url":null,"abstract":"<p><strong>Introduction: </strong>Radiofrequency ablation is a treatment for facetogenic low back pain that targets medial branches of lumbar dorsal rami to denervate facet joints. Clinical outcomes vary; optimizing cannula placement to better capture the medial branch may improve clinical outcomes. A novel parasagittal technique was proposed from an anatomical model; this technique was proposed to optimize capture of the medial branch. The anatomical feasibility of the novel technique has not been evaluated.</p><p><strong>Objective: </strong>To simulate and evaluate the proposed parasagittal technique in its ability to achieve proper cannula placement, and proximity of uninsulated cannula tips to the medial branches of the dorsal rami in cadaveric specimens.</p><p><strong>Materials and methods: </strong>Under fluoroscopic guidance, 14 cannulae were placed using the parasagittal technique targeting the lumbar medial branches of two cadavers. Meticulous dissection was undertaken to assess cannula alignment and measure proximities to target nerves using a digital caliper.</p><p><strong>Results: </strong>The novel parasagittal technique was successfully performed in a cadaveric model in 12/14 attempts. The technique achieved close proximity of cannula tips to medial branches (0.8 ± 1.1 mm). In two instances cannulae were placed unsuccessfully, where one cannula was too far anterior, the other too far retracted.</p><p><strong>Conclusion: </strong>In this cadaveric simulation study, the feasibility of performing the parasagittal technique for lumbar radiofrequency ablation was evaluated. This study suggests the parasagittal technique is a feasible option for lumbar medial branch radiofrequency ablation.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single Arm Feasibility Trial of a Mobile Application for Adolescent Migraine Management. 青少年偏头痛管理移动应用单臂可行性试验
IF 2.9 3区 医学
Pain Medicine Pub Date : 2024-11-05 DOI: 10.1093/pm/pnae111
Amy E Noser, Abigail S Robbertz, James Peugh, Marielle Kabbouche, Joanne Kacperski, Scott W Powers, Andrew D Hershey, Kevin A Hommel
{"title":"Single Arm Feasibility Trial of a Mobile Application for Adolescent Migraine Management.","authors":"Amy E Noser, Abigail S Robbertz, James Peugh, Marielle Kabbouche, Joanne Kacperski, Scott W Powers, Andrew D Hershey, Kevin A Hommel","doi":"10.1093/pm/pnae111","DOIUrl":"https://doi.org/10.1093/pm/pnae111","url":null,"abstract":"","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142581895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The NIH Pain Common Data Elements: A Great Start but a Long Way to the Finish Line. 美国国立卫生研究院疼痛通用数据元素:良好的开端,但距离终点还有很长的路要走。
IF 2.9 3区 医学
Pain Medicine Pub Date : 2024-11-04 DOI: 10.1093/pm/pnae110
Meredith C B Adams, Afton L Hassett, Daniel J Clauw, Robert W Hurley
{"title":"The NIH Pain Common Data Elements: A Great Start but a Long Way to the Finish Line.","authors":"Meredith C B Adams, Afton L Hassett, Daniel J Clauw, Robert W Hurley","doi":"10.1093/pm/pnae110","DOIUrl":"https://doi.org/10.1093/pm/pnae110","url":null,"abstract":"<p><strong>Background: </strong>The NIH Pain Common Data Elements (CDEs) provide a standardized framework for pain research, but their implementation and interpretation present challenges.</p><p><strong>Objectives: </strong>To review the NIH CDE Program's selected pain domains, provide best practices for implementing required questions, and offer a checklist for appropriate CDE use in clinical trials and secondary data analysis.</p><p><strong>Methods: </strong>This work analyzed the ten core pain research domains selected by the NIH CDE Program and discuss their limitations and considerations for use.</p><p><strong>Results: </strong>The manuscript provides an overview of the ten core pain research domains, including pain intensity, interference, physical function, sleep, catastrophizing, depression, anxiety, global impression of change, substance use screening, and quality of life. It offers sample scenarios for implementing required questions and presents a checklist to guide researchers in using pain CDEs effectively for clinical trials and secondary data analysis.</p><p><strong>Discussion: </strong>Key challenges identified include contextual variability, lack of validation across all pain conditions and populations, and potential misuse or misinterpretation of measures. This work proposes solutions such as supplementary measures, context-specific guidance, comprehensive training programs, and ongoing refinement of the CDE framework.</p><p><strong>Conclusion: </strong>While NIH Pain CDEs are valuable tools for standardizing pain assessment in research, addressing challenges in their implementation and interpretation is crucial for improving the consistency, validity, and interpretability of pain research data, ultimately advancing the field and enhancing patient care.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142569227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Varying definitions of long-term opioid therapy: examining prevalence, prescription patterns, and substance-related adverse outcomes. 阿片类药物长期治疗的不同定义:研究患病率、处方模式和与药物相关的不良后果。
IF 2.9 3区 医学
Pain Medicine Pub Date : 2024-11-01 DOI: 10.1093/pm/pnae051
Patrick D Quinn, Olena Mazurenko, Richard Meraz, Zheng Chang, Toyya A Pujol, Adam T Hirsh, Arvid Sjölander, Kurt Kroenke, Brian M D'Onofrio
{"title":"Varying definitions of long-term opioid therapy: examining prevalence, prescription patterns, and substance-related adverse outcomes.","authors":"Patrick D Quinn, Olena Mazurenko, Richard Meraz, Zheng Chang, Toyya A Pujol, Adam T Hirsh, Arvid Sjölander, Kurt Kroenke, Brian M D'Onofrio","doi":"10.1093/pm/pnae051","DOIUrl":"10.1093/pm/pnae051","url":null,"abstract":"","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532629/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141432517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analgesic effects of intraperitoneal lidocaine in adults undergoing surgery: a systematic review and meta-analysis with trial sequential analysis. 接受手术的成人腹腔内利多卡因的镇痛效果:系统综述与试验序列分析》。
IF 2.9 3区 医学
Pain Medicine Pub Date : 2024-11-01 DOI: 10.1093/pm/pnae052
Ka Ting Ng, Wei En Lim, Wan Yi Teoh, Mohd Fitry Bin Zainal Abidin
{"title":"Analgesic effects of intraperitoneal lidocaine in adults undergoing surgery: a systematic review and meta-analysis with trial sequential analysis.","authors":"Ka Ting Ng, Wei En Lim, Wan Yi Teoh, Mohd Fitry Bin Zainal Abidin","doi":"10.1093/pm/pnae052","DOIUrl":"10.1093/pm/pnae052","url":null,"abstract":"<p><strong>Objective: </strong>The administration of local anesthesia in intraperitoneal space as part of the multi-modal analgesic regimen has shown to be effective in reducing postoperative pain. Recent studies demonstrated that intraperitoneal lidocaine may provide analgesic effects. Primary objective was to determine the impact of intraperitoneal lidocaine on postoperative pain scores at rest.</p><p><strong>Design: </strong>We carried out a systematic review and meta-analysis according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).</p><p><strong>Methods: </strong>Databases of MEDLINE, EMBASE, and CENTRAL were searched from their inception date until May 2023. Randomized clinical trials (RCT) comparing intraperitoneal lidocaine and placebo in adults undergoing surgery were included.</p><p><strong>Results: </strong>Our systematic review included 24 RCTs (n = 1824). The intraperitoneal lidocaine group was significantly associated with lower postoperative pain scores at rest (MD, -0.87, 95% CI, -1.04 to -0.69) and at movement (MD, -0.50, 95% CI, -0.93 to -0.08) among adult patients after surgery. Its administration also significantly decreased morphine consumption (MD, -6.42 mg, 95% CI, -11.56 to -1.27) and lowered the incidence of needing analgesia (OR, 0.22, 95% CI, 0.14 to 0.35). Intraperitoneal lidocaine statistically reduced time to resume regular diet (MD, 0.16 days; 95% CI, -0.31 to -0.01) and lowered postoperative incidence of nausea and vomiting (OR, 0.54, 95% CI, 0.39 to 0.75).</p><p><strong>Conclusions: </strong>In this review, our findings should be interpreted with caution. Future studies are warranted to determine the optimal dose of administering intraperitoneal lidocaine among adult patients undergoing surgery.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141446612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can ultrasound-guided medial branch blocks be used to select patients for cervical facet joint radiofrequency neurotomy? A matched retrospective cohort validation study. 超声引导下的内侧支阻滞可用于选择颈椎面关节射频神经切除术的患者吗?- 一项匹配的回顾性队列验证研究。
IF 2.9 3区 医学
Pain Medicine Pub Date : 2024-11-01 DOI: 10.1093/pm/pnae054
Robert Burnham, Rory Trow, James Trow, Ashley Smith, Taylor Burnham
{"title":"Can ultrasound-guided medial branch blocks be used to select patients for cervical facet joint radiofrequency neurotomy? A matched retrospective cohort validation study.","authors":"Robert Burnham, Rory Trow, James Trow, Ashley Smith, Taylor Burnham","doi":"10.1093/pm/pnae054","DOIUrl":"10.1093/pm/pnae054","url":null,"abstract":"<p><strong>Background: </strong>Medial branch blocks are used to select patients for cervical facet joint radiofrequency neurotomy (CRFN). Blocks are typically performed under fluoroscopic guidance (ie, fluoroscopy-guided blocks [FLBs]). The validity of ultrasound-guided blocks (USBs) is not well established. No prior research has compared cervical USB validity and FLB validity with CRFN outcome used as the criterion standard.</p><p><strong>Objective: </strong>To evaluate cervical USB versus FLB validity with CRFN outcome used as the criterion standard.</p><p><strong>Methods: </strong>Demographic and outcome data were extracted from the electronic medical records of 2 affiliated musculoskeletal pain management clinics for all patients between 2015 and 2023 inclusive who had cervical USB leading to CRFN. CRFN outcomes of each USB patient were compared with those of a matched FLB patient from the radiofrequency neurotomy (RFN) outcome database of the same clinics. Matching variables included patient age, sex, pain duration, diagnostic/prognostic block paradigm, and CRFN number. Each patient completed a numeric rating scale (NRS) pain score and Pain Disability Quality-of-Life Questionnaire (PDQQ) just before and 3 months after CRFN. At repeat CRFN, patients provided a retrospective estimate of the duration and average magnitude (percentage) of relief after the CRFN.</p><p><strong>Results: </strong>USB and FLB groups were comprised of 27 patients (58 RFNs) and 38 patients (58 RFNs), respectively. Post-RFN NRS pain severity and PDQQ-Spine scores demonstrated comparable (P > .05) absolute improvements, proportion of patients achieving ≥50% improvement, and attainment of the minimum clinically important difference. Retrospective estimates of pain relief magnitude and duration were also comparable.</p><p><strong>Conclusions: </strong>This study finds cervical USB and FLB to be comparably valid as defined by their ability to predict CRFN outcome. Within the limitations of operator competence, USB can be used to select patients for CRFN.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141469918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initial development of a self-report survey on use of Nonpharmacological and Self-Care Approaches for Pain management (NSCAP). 关于使用非药物和自我护理方法治疗疼痛的自我报告调查 (NSCAP) 的初步开发。
IF 2.9 3区 医学
Pain Medicine Pub Date : 2024-11-01 DOI: 10.1093/pm/pnae082
Sara N Edmond, Robert D Kerns, Mary Geda, Stephen L Luther, Robert R Edwards, Stephanie L Taylor, Marc I Rosen, Julie M Fritz, Christine M Goertz, Steven B Zeliadt, Karen H Seal
{"title":"Initial development of a self-report survey on use of Nonpharmacological and Self-Care Approaches for Pain management (NSCAP).","authors":"Sara N Edmond, Robert D Kerns, Mary Geda, Stephen L Luther, Robert R Edwards, Stephanie L Taylor, Marc I Rosen, Julie M Fritz, Christine M Goertz, Steven B Zeliadt, Karen H Seal","doi":"10.1093/pm/pnae082","DOIUrl":"10.1093/pm/pnae082","url":null,"abstract":"","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11548860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142009191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuropsychiatric drugs and a neurophysiological marker as predictors of health-related quality of life in patients with phantom limb pain. 预测幻肢痛患者健康相关生活质量的神经精神药物和神经生理标志物。
IF 2.9 3区 医学
Pain Medicine Pub Date : 2024-11-01 DOI: 10.1093/pm/pnae053
Valton Costa, Kevin Pacheco-Barrios, Anna Carolyna Gianlorenço, Felipe Fregni
{"title":"Neuropsychiatric drugs and a neurophysiological marker as predictors of health-related quality of life in patients with phantom limb pain.","authors":"Valton Costa, Kevin Pacheco-Barrios, Anna Carolyna Gianlorenço, Felipe Fregni","doi":"10.1093/pm/pnae053","DOIUrl":"10.1093/pm/pnae053","url":null,"abstract":"<p><strong>Objective: </strong>To explore the relationship between sociodemographic, clinical, and neurophysiological variables and health-related quality of life (HR-QOL) of patients with phantom limb pain (PLP).</p><p><strong>Methods: </strong>This is a cross-sectional analysis of a previous clinical trial. Univariate and multivariate linear and logistic regression analyses were used to model the predictors of HR-QOL. We utilized a sequential modeling approach with increasing adjustment levels, controlling for age and sex, and other relevant clinical variables (time since amputation, level of amputation, and pain). HR-QOL was assessed by the SF-36 Health Survey and its 8 subdomains.</p><p><strong>Results: </strong>We analyzed baseline data from 92 patients with lower-limb amputations. They were mostly male (63%), 45.2 ± 15.6 years, with a mean time since amputation of 82.7 ± 122.4 months, and an overall SF-36 score of 55.9 ± 21.5. We found an association between intracortical facilitation (ICF) in the affected hemisphere, gabapentin usage, and HR-QOL. ICF is a predictor of better HRQOL, whereas gabapentin usage was associated with a poorer HR-QOL, with the main model explaining 13.4% of the variance in the outcome. For the SF-36 subdomains, ICF was also a positive predictor for social functioning, bodily pain, and vitality, while medication usage was associated with lower scores in mental health, general health perception, bodily pain, and vitality.</p><p><strong>Conclusion: </strong>We found firsthand 2 new independent predictors of HR-QOL in individuals with PLP, namely, the neurophysiological metric ICF and gabapentin usage. These results highlight the role of the motor cortex excitability in the HR-QOL and stress the need for treatments that favor the neuroplastic adaptation after amputation, for which ICF may be used as a possible marker.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532630/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of fremanezumab treatment in patients with migraine headache. 治疗偏头痛患者的氟马尼单抗疗效。
IF 2.9 3区 医学
Pain Medicine Pub Date : 2024-11-01 DOI: 10.1093/pm/pnae050
Shoji Kikui, Danno Daisuke, Junichi Miyahara, Hanako Sugiyama, Kuniko Ota, Kenji Murakata, Yoshihiro Kashiwaya, Takao Takeshima
{"title":"Effectiveness of fremanezumab treatment in patients with migraine headache.","authors":"Shoji Kikui, Danno Daisuke, Junichi Miyahara, Hanako Sugiyama, Kuniko Ota, Kenji Murakata, Yoshihiro Kashiwaya, Takao Takeshima","doi":"10.1093/pm/pnae050","DOIUrl":"10.1093/pm/pnae050","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the efficacy and safety of fremanezumab for migraine prevention.</p><p><strong>Design: </strong>Retrospective, single-center, real-world study.</p><p><strong>Setting: </strong>Regional tertiary headache center in Japan.</p><p><strong>Subjects: </strong>Adult individuals with migraine (n = 165, male = 17, female = 148; average age = 45.5 ± 16.0 years) who received fremanezumab between September 2021 and August 2022.</p><p><strong>Methods: </strong>Fremanezumab was administered subcutaneously at a monthly dose of 225 mg or quarterly dose of 675 mg based on patient preferences. Patients received fremanezumab treatment for up to 1 year unless it was discontinued. Monthly data were collected on migraine days, headache days, and days requiring acute medication.</p><p><strong>Results: </strong>Of the 165 patients, 125 (75.7%) received fremanezumab as their first anti-calcitonin gene-related peptide-related antibody drug. Significant reductions in monthly migraine days, headache days, and days requiring acute medication were observed in those with episodic and chronic migraines. The baseline monthly headache days was 8.1 ± 4.0 in the episodic migraine group, which reduced to 6.1 ± 4.8, 5.8 ± 4.4, 4.7 ± 3.6, and 4.6 ± 3.3 days at 1, 3, 6, and 12 months, respectively; in the chronic migraine group, the baseline monthly headache days was 20.9 ± 6.1, which reduced to 17.0 ± 8.9, 15.0 ± 9.2, 13.0 ± 7.7, and 12.0 ± 9.1 days at 1, 3, 6, and 12 months, respectively. Treatment benefits were enhanced after 6 months of administering fremanezumab in the chronic migraine group.</p><p><strong>Conclusions: </strong>In this real-world study of patients with migraine, fremanezumab appears to be effective and safe. Further studies are required to identify additional predictors of treatment success and failure with fremanezumab.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141420243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engaging clinical partners in pragmatic clinical trials: lessons learned from the pain management collaboratory. 让临床合作伙伴参与实用临床试验:从疼痛管理合作组织中汲取的经验教训。
IF 2.9 3区 医学
Pain Medicine Pub Date : 2024-11-01 DOI: 10.1093/pm/pnae055
Lori A Bastian, Steven P Cohen, Stacie A Salsbury, Alison F Davis, Lily Katsovich, Robert D Kerns
{"title":"Engaging clinical partners in pragmatic clinical trials: lessons learned from the pain management collaboratory.","authors":"Lori A Bastian, Steven P Cohen, Stacie A Salsbury, Alison F Davis, Lily Katsovich, Robert D Kerns","doi":"10.1093/pm/pnae055","DOIUrl":"10.1093/pm/pnae055","url":null,"abstract":"","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11548849/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信